Culture

'Classic triad' of symptoms misses positive COVID-19 cases, study finds

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

New research led by researchers at King's College London and published in the Journal of Infection suggests that restricting testing to the 'classic triad' of cough, fever and loss of smell which is required for eligibility for a PCR test through the NHS may have missed cases. Extending the list to include fatigue, sore throat, headache and diarrhoea would have detected 96% of symptomatic cases.

A team of researchers at King's College London and the Coalition for Epidemic Preparedness Innovations (CEPI) analysed data from more than 122,000 UK adult users of the ZOE COVID Symptom Study app. These users reported experiencing any potential COVID-19 symptoms, and 1,202 of those reported a positive PCR test within a week of first feeling ill.

While PCR swab testing is the most reliable way to tell whether someone is infected with the SARS-CoV-2 coronavirus that causes COVID-19, the analysis suggests the limited list of three does not catch all positive cases of COVID-19.

Testing people with any of the three 'classic' symptoms would have spotted 69% of symptomatic cases, with 46 people testing negative for every person testing positive. However, testing people with any of seven key symptoms - cough, fever, anosmia, fatigue, headache, sore throat and diarrhoea - in the first three days of illness would have detected 96% of symptomatic cases. In this case, for every person with the disease identified, 95 would test negative.

Researchers also found users of the Symptom Study App were more likely to select headache and diarrhoea within the first three days of symptoms, and fever during the first seven days, which reflects different timings of symptoms in the disease course. Data from the ZOE app shows that 31% of people who are ill with COVID-19 don't have any of the triad of symptoms in the early stages of the disease when most infectious.

The researchers applied a multi-objective evolutionary algorithm (MOEA) to generate a set of optimal symptom combinations, each characterised by a good trade-off between specificity and sensitivity. MOEA starts generating a population of random symptom combinations and then evolves that population towards better combinations ending with a set of optimal symptom combinations. The choice of the optimal combination to use depends on the testing capacity.

Cough or dyspnoea (shortness of breath) were reported by 46% of individuals positive for COVID-19 within the first three days of symptom onset. When users reported fever, the sensitivity increased to 60%, while logging anosmia/ageusia increased sensitivity to 69%. When headache and fatigue was added the proportion of COVID-19 cases increased to 92% but the tests per case doubled.

The findings may be valuable in situations where there is a limited testing capacity. Researchers suggest a range of optimal symptom combinations that could be used in vaccine efficacy trials or in public health settings, when assessing financial and logistical resources.

Professor Sebastien Ourselin from King's College London said: ""The identification of this combination of symptoms through the COVID Symptom Study app is another prime demonstration of the value of big data analytics and mobile health technology to support the management of this pandemic. Daily self-reported symptoms from a mobile application at the scale of an entire country has offered a new perspective for public health research and response towards the rapid spread of infectious diseases such as COVID-19."

Dr Claire Steves, Reader at King's College London, said: "There are many symptoms which occur in acute COVID, including some like fatigue and headache which are also common in other conditions. Depending on the testing available, different symptom combinations can be used to be as sensitive or specific as possible. We hope these models are of use in a range of settings - from vaccine trials to detecting and treating COVID outbreaks going forward."

Professor Tim Spector from King's College London said: "We've known since the beginning that just focusing testing on the classic triad of cough, fever and anosmia misses a significant proportion of positive cases. We identified anosmia as a symptom back in May and our work led to the government adding it to the list, it is now clear that we need to add more. By inviting any users who log any new symptoms to get a test, we confirmed that there are many more symptoms of COVID-19. This is especially important with new variants that may cause different symptoms. For us, the message for the public is clear: if you're feeling newly unwell, it could be COVID and you should get a test."

Dr Jakob Cramer, Head of Clinical Development, at the Coalition for Epidemic Preparedness Innovations, said: "Accurate diagnosis of COVID-19 cases is crucial when assessing the efficacy of COVID-19 vaccine candidates in large-scale studies, especially since the signs and symptoms associated with the disease are extensive and overlap with other common viral infections. The findings of this study provide important insights that will help optimise the choice of triggering symptoms for diagnostic work-up in COVID-19 vaccine-efficacy trials. We hope the findings of this study will not only aid CEPI's COVID-19 vaccine-development partners but also the wider R&D community."

Credit: 
King's College London

Supercomputer turns back cosmic clock

image: Schematic diagram of the evolution of the Universe from the inflation (left) to the present (right). The "reconstruction method" winds back the evolution from right to left on this illustration to reproduce the primordial density fluctuations from the current galaxy distribution.

Image: 
The Institute of Statistical Mathematics

Astronomers have tested a method for reconstructing the state of the early Universe by applying it to 4000 simulated universes using the ATERUI II supercomputer at the National Astronomical Observatory of Japan (NAOJ). They found that together with new observations the method can set better constraints on inflation, one of the most enigmatic events in the history of the Universe. The method can shorten the observation time required to distinguish between various inflation theories.

Just after the Universe came into existence 13.8 billion years ago, it suddenly increased more than a trillion, trillion times in size, in less than a trillionth of a trillionth of a microsecond; but no one knows how or why. This sudden "inflation," is one of the most important mysteries in modern astronomy. Inflation should have created primordial density fluctuations which would have affected the distribution of where galaxies developed. Thus, mapping the distribution of galaxies can rule out models for inflation which don't match the observed data.

However, processes other than inflation also impact galaxy distribution, making it difficult to derive information about inflation directly from observations of the large-scale structure of the Universe, the cosmic web comprised of countless galaxies. In particular, the gravitationally driven growth of groups of galaxies can obscure the primordial density fluctuations.

A research team led by Masato Shirasaki, an assistant professor at NAOJ and the Institute of Statistical Mathematics, thought to apply a "reconstruction method" to turn back the clock and remove the gravitational effects from the large-scale structure. They used ATERUI II, the world's fastest supercomputer dedicated to astronomy simulations, to create 4000 simulated universes and evolve them through gravitationally driven growth. They then applied this method to see how well it reconstructed the starting state of the simulations. The team found that their method can correct for the gravitational effects and improve the constraints on primordial density fluctuations.

"We found that this method is very effective," says Shirasaki. "Using this method, we can verify of the inflation theories with roughly one tenth the amount of data. This method can shorten the required observing time in upcoming galaxy survey missions such as SuMIRe by NAOJ's Subaru Telescope."

Credit: 
Research Organization of Information and Systems

Ultraviolet 'television' for animals helps us better understand them

video: A clownfish watching the UQ-developed ultraviolet 'television' display in an experiment.

Image: 
The University of Queensland

University of Queensland scientists have developed an ultraviolet 'television' display designed to help researchers better understand how animals see the world.

Until now, standard monitors on devices like televisions or computer screens have been used to display visual stimuli in animal vision studies, but none have been able to test ultraviolet vision - the ability to see wavelengths of light shorter than 400 nanometres.

Dr Samuel Powell, from the Queensland Brain Institute's Marshall lab, said this new technology will help unveil the secrets of sight in all sorts of animals, such as fish, birds and insects.

"Human TVs generally use three colours - red, green and blue - to create images, but our newly-developed displays have five, including violet and ultraviolet," Dr Powell said.

"Using this display, it's now possible to show animals simple shapes, to test their ability to tell colours apart, or their perception of motion by moving dot patterns.

"We affectionately call it the 'UV-TV', but I doubt that anyone would want one in their home!

"You'd have to wear sunglasses and sunscreen while watching it, and the resolution is quite low - 8 by 12 pixels in a 4 by 5 centimetre area - so don't expect to be watching Netflix in ultraviolet anytime soon.

"This very low resolution is enough to show dot patterns to test fish perception, in what's known as an Ishihara test, which would be familiar to anyone who's been tested for colour blindness.

"In this test, humans read a number hidden in a bunch of coloured dots, but as animals can't read numbers back to us, they're trained to peck the 'odd dot' out of a field of differently coloured dots."

Dr Karen Cheney from UQ's School of Biological Sciences said this technology will allow researchers to expand our understanding of animal biology.

"There are many colour patterns in nature that are invisible to us because we cannot detect UV," Dr Cheney said.

"Bees use UV patterns on flowers to locate nectar, for example, and fish can recognise individuals using UV facial patterns.

"We've recently started studying the vision of anemonefish or clownfish - aka, Nemo - which, unlike humans, have UV-sensitive vision.

"Our research is already showing that the white stripes on anemonefish also reflect UV, so we think UV colour signals may be used to recognise each other and may be involved in signalling dominance within their social group.

"Who knows what other discoveries we can now make about how certain animals behave, interact and think.

"This technology is allowing us to understand how animals see the world, helping answer significant questions about animal behaviour."

Credit: 
University of Queensland

Electron cryo-microscopy sheds light on how bioenergy makers are made in our body

image: Mitoribosomes are tethered to the mitochondrial inner membrane to facilitate insertion of synthesized proteins (yellow) encoded by the mitochondrial genome. A gating mechanism of the exit tunnel (cyan) enables protein delivery to the membrane insertase OXA1L (light brown).

Image: 
Dan W. Nowakowski and Alexey Amunts

Mitochondria are organelles that act as the powerhouses in our body. They use oxygen which we inhale and food we eat to produce energy that supports our life. This molecular activity is performed by bioenergetic nano-factories incorporated in specialized mitochondrial membranes. The nano-factories consist of proteins cooperatively transporting ions and electrons to generate chemical energy. Those have to be constantly maintained, replaced and duplicated during cell division. To address this, mitochondria have their own bioenergy protein-making machine called the mitoribosome. Given its key role, a deregulation of the mitoribosome can lead to medical disorders such as deafness and diseases including cancer development. The first fundamental understanding of how mitoribosomes look was achieved in 2014.

"Seven years ago, our work on the structure of mitoribosome from yeast was termed the Resolution Revolution. The current study represents an additional advance on the original breakthrough. Not only does it reveal how the human mitoribosome is designed at an unprecedented level of detail, but it also explains the molecular mechanism that drives the process of bioenergetics to fuel life" says lead author, Alexey Amunts.

The term Resolution Revolution was coined at Science magazine in relation to the first successful structure determination of the mitoribosome. This represented a methodological innovation in applying electron cryo-microscopy to understand molecular structures. However, that first glimpse into the architecture revealed only a partial picture of a static model. Yet the mitoribosome is a flexible molecular machine that requires the motion of its parts relative to each other to perform work. Therefore, in the current study the team used an advanced infrastructure to collect and process 30 times more data that enabled them to obtain enough information to describe conformational changes during the process of protein synthesis and association with the membrane adaptor.

"Our study reveals that the mitoribosome is much more flexible and active than previously thought. The discovery of intrinsic conformational changes represents a gating mechanism of the mitoribosome without similarity in bacterial and cytosolic systems. Together, the data offer a molecular insight into how bioenergetic proteins are synthesized in human mitochondria," adds Alexey Amunts.

The sequencing of the human mitochondrial genome 40 years ago was a turning point in mitochondrial research, postulating a putative specialized mechanism for the synthesis of the mitochondrial transmembrane proteins. The discovered gating mechanism of the human mitoribosome represents a unique occurrence. Therefore, the structural data offer a crucial long-waited understanding into how bioenergetic proteins are synthesized by the mitoribosome in our body. This knowledge will help to better understand human diseases and be used for development of new therapeutics.

Credit: 
Science For Life Laboratory

Setting hospital prices would save more than increasing competition or price transparency

Among strategies to curb hospital prices among the commercially insured population in the U.S., direct price regulations such as setting rates are likely to achieve greater savings than other approaches like increasing competition or improving price transparency, according to a new RAND Corporation study.

But price regulations face the greatest political obstacles and historically have been strongly opposed by medical providers, according to the report.

Setting prices for all commercial health care payers could reduce hospital spending by $61.9 billion to $236.6 billion annually if the rates were set as high as 150% to as low as 100% of the amounts paid by the federal Medicare program, a change that would cut overall national health spending by 1.7% to 6.5%, according to the analysis.

Researchers estimate that improving health care price transparency could reduce U.S. spending by $8.7 billion to $26.6 billion per year. Meanwhile, increasing competition by decreasing hospital market concentration could reduce hospital spending by $6.2 billion to $68.9 billion annually, depending on the magnitude of the change and how sensitive hospital prices are to market concentration.

"Improving markets through increased price transparency and competition could help reduce prices, but would not reduce hospital spending to the extent that aggressively regulating prices could," said Jodi Liu, the study's lead author and a policy researcher at RAND, a nonprofit research organization. "Direct price regulation could have the largest impact on hospital spending, but this approach faces the biggest political challenges."

Spending on hospital services is the largest health spending category in the United States, accounting for one-third of national health expenses.

Private insurers such as employers and insurance companies cover about 40% of hospital spending. Compared with public payers, private insurers pay higher prices to hospitals and those costs have risen faster over time.

The RAND study analyzes the impact of three policy options -- regulating hospital prices, improving price transparency and increasing competition among hospitals -- on hospital spending by employer-sponsored and individual market plans and their enrollees.

Using nationwide data from the federal Hospital Cost Report Information System, researchers explored key considerations for each strategy and estimated the potential impact on hospital prices and spending.

The report provides a menu of policy scenarios to help policymakers understand how key design choices or stakeholder responses might affect the impact of a given policy.

For example, the effectiveness of price transparency initiatives would depend on details such as whether patients would use price transparency tools to choose lower-cost providers. RAND researchers modeled both patient-driven scenarios, in which patients use price information to seek lower prices, and employer-driven scenarios, in which employers use price information to create health plans that steer patients toward lower-cost hospitals.

For rate-setting scenarios, researchers changed average commercial plan prices to an amount relative to Medicare prices for a given hospital. Prices were pegged to multiples of the Medicare price, as well as blended rates in between commercial and Medicare prices (such as using 25% of the Medicare rate and 75% of the commercial rate).

Researchers modeled competition scenarios by reducing hospital market concentration in hospital referral regions, computing a price reduction with respect to the change in market concentration.

However, researchers concluded that given how concentrated today's hospital markets are, policymakers would need to radically restructure hospital markets beyond what the study modeled for prices to approach competitive levels.

"Regulating commercial hospital prices is a direct way to create significant reductions in spending, but doing so could potentially lead to hospital closures, erode quality, and face daunting political hurdles," said study co-author Christopher Whaley, a RAND policy researcher. "As policymakers consider options for reducing hospital prices paid by private health plans, they will need to weigh the potential impact of different policies on hospital revenues and the quality of care, and they will also need to take into account the political and administrative feasibility of each option."

Credit: 
RAND Corporation

How likely are consumers to adopt artificial intelligence for banking advice?

A new study published in Economic Inquiry is the first to assess the willingness of consumers to adopt advisory services in the banking sector that are based on artificial intelligence (AI). Investigators examined whether the likelihood that consumers adopt AI in banking services depends on tastes for human interaction across different cultures.

The study focused on robo-advisory services, which are automated investment platforms that provide investment advice without the intervention of a human advisor. When investigators analyzed an ING Bank dataset encompassing 11,000 respondents from 11 countries, they found that different attitudes across cultures shape differences in local consumers' likelihood of adopting robo-advisory services.

The analysis revealed that robo-advisory services may be adopted where they compensate for feelings of a lack of trust and reliability towards human advisors among consumers. Also, fear of being cheated had a strong influence in enhancing consumers' preference to use AI. Places where social interaction is considered important did not welcome the AI novelty, even when controlling for all of the usual factors that determine the adoption of new technology.

"There is some special value that people place on human interaction in services, which an AI-based service simply cannot substitute. Even when using a classical economic model for the adoption of innovation, such as the model by eminent economist Arrow and co-authors (previously used for understanding the adoption of new medicines), we see that the value of human interaction shows a clear importance for the AI customer in the service sector," said corresponding Annie Tubadji, PhD, of Swansea University.

Credit: 
Wiley

As insurers end grace period for COVID-19 hospital costs, study estimates potential bills

Nearly 1.7 million times in the past year, Americans have checked into hospitals to get treated for severe cases of COVID-19.

And for the most part, that care hasn't cost them anything, thanks to insurance companies and government programs that absorbed the usual costs patients would owe for any other hospital stay.

But as some insurers phase back in those out-of-pocket costs, a new study estimates that many people over 65 hospitalized for COVID-19 in 2021 may owe an average of nearly $1,000 after they get out of the hospital, due to co-pays, deductibles and co-insurance. A few may owe hundreds or thousands more.

That estimate is based on a new analysis of out-of-pocket costs for influenza-related hospitalizations in 2018 that were paid by people with Medicare Advantage plans, which are Medicare plans run by private insurance companies.

Nearly 40% of Americans over age 65 - who have a high chance of needing hospital-level care if they catch the coronavirus - have the kind of insurance analyzed in the study.

Most insurers that offer Medicare Advantage plans currently cover COVID-19 hospitalization costs fully for their Medicare Advantage enrollees, but one of these insurers quietly started to allow cost-sharing for its non-Medicare Advantage enrollees in February. This raises concerns that cost-sharing waivers may soon be a thing of the past for many or all patients hospitalized for COVID-19.

"Insurers may choose to extend their waivers for enrollees with Medicare Advantage and private insurance coverage," says Kao-Ping Chua, M.D., Ph.D., the study's first author and an assistant professor at the U-M Medical School. "But if they don't, patients will be faced not only with the physical and emotional toll of COVID-19 hospitalizations, but also the financial toll."

Writing in the American Journal of Preventive Medicine, a pair of health care researchers from the University of Michigan and Boston University describe data from 14,278 people hospitalized during one of the worst flu years in recent times.

On average, the flu patients in the study were hospitalized for an average of 6 days, and one-third of patients needed intensive care. This is around the same or slightly lower than the averages for hospitalized adults over 65 who have COVID-19.

Those who needed intensive care for flu, and those with longer stays at any level of care, faced out-of-pocket costs that were higher than the general average. About 3% of the flu patients faced out-of-pocket costs over $2,500.

Another study of cost-sharing among people with private non-Medicare insurance who were hospitalized for respiratory infections in pre-COVID times suggests out-of-pocket costs could be even higher for them. In part this is because so many private plans have high deductibles that must be paid each year before insurance coverage fully kicks in.

Chua notes that the choice of flu or other respiratory infection hospitalizations is not a perfect stand-in for COVID-19, which is having far more impact on the United States than even the worst flu year. But it is as close a stand-in as possible.

People with traditional Medicare also must share in the cost of their hospital care, but the current study did not analyze data from people with that form of coverage.

In 2018, 40% of Americans lacked enough savings to pay for a $400 emergency, according to federal data. The pandemic has put even more economic pressure on the lowest-income Americans.

Chua and his co-author Rena Conti, Ph.D. of Boston University's Institute for Health System Innovation and Policy, note that worries about out-of-pocket costs might keep some people from seeking emergency or inpatient care. They call for federal legislation mandating insurers to fully cover the costs of COVID-19 hospitalizations for the duration of the pandemic, and for insurers to extend waivers due to expire soon.

Credit: 
Michigan Medicine - University of Michigan

AI may mistake chess discussions as racist talk

PITTSBURGH--"The Queen's Gambit," the recent TV mini-series about a chess master, may have stirred increased interest in chess, but a word to the wise: social media talk about game-piece colors could lead to misunderstandings, at least for hate-speech detection software.

That's what a pair of Carnegie Mellon University researchers suspect happened to Antonio Radi?, or "agadmator," a Croatian chess player who hosts a popular YouTube channel. Last June, his account was blocked for "harmful and dangerous" content.

YouTube never provided an explanation and reinstated the channel within 24 hours, said Ashiqur R. KhudaBukhsh a project scientist in CMU's Language Technologies Institute (LTI). It's nevertheless possible that "black vs. white" talk during Radi?'s interview with Grandmaster Hikaru Nakamura triggered software that automatically detects racist language, he suggested.

"We don't know what tools YouTube uses, but if they rely on artificial intelligence to detect racist language, this kind of accident can happen," KhudaBukhsh said. And if it happened publicly to someone as high-profile as Radi?, it may well be happening quietly to lots of other people who are not so well known.

To see if this was feasible, KhudaBukhsh and Rupak Sarkar, an LTI course research engineer, tested two state-of-the-art speech classifiers -- a type of AI software that can be trained to detect indications of hate speech. They used the classifiers to screen more than 680,000 comments gathered from five popular chess-focused YouTube channels.

They then randomly sampled 1,000 comments that at least one of the classifiers had flagged as hate speech. When they manually reviewed those comments, they found that the vast majority -- 82% -- did not include hate speech. Words such as black, white, attack and threat seemed to be triggers, they said.

As with other AI programs that depend on machine learning, these classifiers are trained with large numbers of examples and their accuracy can vary depending on the set of examples used.

For instance, KhudaBukhsh recalled an exercise he encountered as a student, in which the goal was to identify "lazy dogs" and "active dogs" in a set of photos. Many of the training photos of active dogs showed broad expanses of grass because running dogs often were in the distance. As a result, the program sometimes identified photos containing large amounts of grass as examples of active dogs, even if the photos didn't include any dogs.

In the case of chess, many of the training data sets likely include few examples of chess talk, leading to misclassification, he noted.

Credit: 
Carnegie Mellon University

Study finds no gender discrimination when leaders use confident language

PULLMAN, Wash. - People tend to listen to big talkers, whether they are women or men. Still, more women prefer not to use assertive language, according to a new study led by Washington State University economist Shanthi Manian.

The study, published in Management Science on Feb. 17, found that participants in an experiment more often followed advice when the people giving the advice used assertive "cheap talk," statements that cannot be verified as true. Examples of such statements are often found in job seeking cover letters, such as "I have extremely strong problem-solving skills."

The experiment participants followed the advice people gave at similar rates regardless of their gender--even though they thought other people would be less likely to follow the advice of the female leaders.

"It was surprising. We didn't see actual discrimination: the subjects themselves seemed to respond about the same to men and women," said Manian. "Yet, after the experiment was over, and we asked the participants what they thought we'd find, many of them expected discrimination."

For the experiment, Manian and Ketki Sheth, an economist at University of California, Merced, recruited about 1,000 people to play a difficult online game. The players were paired with either a male or female leader, who gave advice online on how to play the game to earn the biggest reward.

Everyone had the same interactions with their leaders, except for two features--the gender of the leader and the assertiveness of the leaders' language. The same advice was couched in language that ranged from less assertive, using statements such as "You probably have better problem-solving skills than I do, but here is what I am thinking," to more assertive, such as "If you listen to my advice, I can assure you that my skills and experiences will help you perform well in this game."

The game was played by about 1,000 people, roughly half were U.C. Merced students and half recruited through Amazon's Mechanical Turk online crowdsourcing portal.

While all the leaders gave the same good advice, the more assertive the leader's statements were, the more people were likely to follow the advice.

However, the researchers found that the participants did not discriminate by gender regardless of the language being used by the leader. The people paired with a female leader who used assertive cheap talk were just as likely to follow the advice as those paired with a male leader using the same language - even though most participants characterized such language as being more masculine.

Also, while previous research has found that when people violate gender norms, they may get punished or face backlash, in this experiment, the participants were just as likely to listen to the female leaders and found them no less likeable.

After the game was played, the researchers asked the participants whether they thought the leaders' gender would matter. People were much more likely to believe that others would follow the advice from a male leader than a female leader, even if the advice was identical.

They were also asked what type of language they would choose if they were leaders in the game. While most men and women avoided the least assertive language, men were ten percentage points more likely to prefer the most assertive language option.

Sheth said the results raise questions about why women prefer less assertive language and what price they may pay for that aversion.

"The fact that the subjects expected discrimination suggests that it's hard for people to know when discrimination is going to happen," said Sheth.

Credit: 
Washington State University

Understanding cellular clock synchronization

image: Mice without a brain clock lose the synchronisation between the different organs, as shown in the bioluminescence profile (right). In the liver, however, synchronisation is maintained.

Image: 
© UNIGE

Circadian clocks, which regulate the metabolic functions of all living beings over a period of about 24 hours, are one of the most fundamental biological mechanisms. In humans, their disruption is the cause of many metabolic diseases such as diabetes or serious liver diseases. Although scientists have been studying this mechanism for many years, little is known about how it works. Thanks to an observation tool based on bioluminescence, a research team from the University of Geneva (UNIGE) were able to demonstrate that cells that compose a particular organ can be in-phase, even in the absence of the central brain clock or of any other clocks in the body. Indeed, the scientists managed to restore circadian function in the liver in completely arrhythmic mice, demonstrating that neurons are not unique in their ability to coordinate. Results can be discovered in the journal Gene and Development.

For a long time, the scientific community considered that circadian rhythms were entirely controlled by a central clock located in the brain, before discovering, a few years ago, the existence in all cells of the body of a small molecular clock. "Nevertheless, the brain clock was deemed indispensable for the synchronization of all peripheral clocks," says Ueli Schibler, honorary professor at the UNIGE Faculty of Science, who initiated the work. "However, usual research tools did not allow us to explore the validity of this hypothesis. Indeed, to do so, we must be able to follow in real time, over a relatively long period of time, the expression of the circadian genes of an animal with or without a functional brain clock," explains Flore Sinturel, researcher at the Department of Medicine of UNIGE Faculty of Medicine and first author of this work.

Bioluminescence to study circadian rhythms

As early as 2013, Professor Schibler's team developed a completely new technology, now commercially available , which makes it possible to monitor the activity of a specific organ and the circadian rhythms that control it. "We were inspired by the principle of bioluminescence that can be observed in fireflies, for example," he explains. "Our mice carry a circadian reporter gene that produces an enzyme, luciferase. We then add luciferin to their drinking water, a substance which, when oxidized by the luciferase, causes photon emission." Light is then captured by a photomultiplier that records the number of photons emitted per minute and thus detects the expression of the circadian reporter gene over time.

Liver clock cells are phase-coupled without receiving timing cues

After the central clock was removed, scientists observed that all the clocks in the body are in different phases. However, at the level of a single organ - the liver in this case - the mice retain a robust and coordinated circadian rhythmicity. So, while the central clock can synchronize all the organs in the same phase, the cells communicate enough to maintain a coordinated rhythmicity within a single organ. "While it was thought that only neurons had strong enough connections to ensure this circadian coordination, we are now demonstrating that this is not the case," says Flore Sinturel. "This puts the singularity of the central clock into perspective."

The scientists then confirmed their discovery: in arrhythmic mice, i.e. mice with no circadian clocks whatsoever, the researchers succeeded in restoring the expression of rhythmicity in the liver alone, without touching the other organs. "This allowed us to show that a clock restored in one organ works and has rhythms, even in the absence of all the other clocks in the body," she explains. They now want to understand how these cells stay in the same phase when they are not receiving any information, either from the brain or from other external signals. Their hypothesis? The existence of a form of coupling, in the form of an exchange of molecules between these different cells.

Credit: 
Université de Genève

3D microscopy clarifies understanding of body's immune response to obesity

image: Xiaohui Zhang, left, Andrew Smith, Kelly Swanson, Erik Nelson, Mark Anastasio and Junlong Geng are part of a team working to clarify the relationship between obesity and inflammation while on the hunt for obesity-fighting drug therapies.

Image: 
Photo by L. Brian Stauffer.

CHAMPAIGN, Ill. -- Researchers who focus on fat know that some adipose tissue is more prone to inflammation-related comorbidities than others, but the reasons why are not well understood. Thanks to a new analytical technique, scientists are getting a clearer view of the microenvironments found within adipose tissue associated with obesity. This advance may illuminate why some adipose tissues are more prone to inflammation - leading to diseases like type 2 diabetes, cancer and cardiovascular disorders - and help direct future drug therapies to treat obesity.

In a new study, University of Illinois Urbana Champaign bioengineering professors Andrew Smith and Mark A. Anastasio, molecular and integrative physiology professor Erik Nelson and nutritional sciences professor Kelly Swanson detail the use of the new technique in mice. The results are published in the journal Science Advances.

Inflammation in adipose tissue presents itself as round complexes of inflammatory tissue called crownlike structures. Previous studies have shown that body fat that contains these structures is associated with worse outcomes of obesity and related metabolic disorders, the study reports.

Previously, researchers were confined to the use of 2D slices of tissue and traditional microscopy, limiting what researchers could learn about them.

To get a better view, the team combined a special type of microscopy that uses a 3D sheet of light rather than a beam, a fat-clearing technique that renders tissue optically transparent, and deep-learning algorithms that help process the large amount of imaging data produced.

The researchers found that the crownlike appearances that gives these structures their name are, in reality, more like 3D shells or concentric spheres surrounding an empty core, Smith said.

"Using our new technique, we can determine the crownlike structures' volume, the specific number of cells associated with them, as well as their size, geometry and distribution," Smith said.

This ability led the team to discover that obesity tends to be associated with a prevalence of rare, massive crownlike structures that are not present in the lean state.

"These very large crownlike structures are clustered together and located in the center of the tissue," Smith said. "And there is no way we could have analyzed this before using our new technique."

Smith said the research may lead to new drug therapies and new ways to evaluate patients' metabolic health.

"Right now, we know that some patients are overweight but metabolically healthy, while others are underweight and metabolically unhealthy," Smith said. "We believe that having the ability to look deep into the microenvironments with fat tissue may unlock some of the reasons why this is."

Credit: 
University of Illinois at Urbana-Champaign, News Bureau

Dr. Frederick Boop presents at the ISPN 2020 Virtual Meeting

Understanding the molecular biology of brain tumors is key to prognosis and treatment said Le Bonheur Neuroscience Institute Co-Director Frederick Boop, MD, in his presentation "How Molecular Biology Impacts Clinical Practice" at the International Society for Pediatric Neurosurgery (ISPN) 2020 Virtual Meeting.

"Historically we have depended on what we see under a microscope to differentiate tumor types and determine prognosis and therapy," said Boop. "We know now that what we see doesn't necessarily predict how these tumors are going to behave."

Physicians are able to send a piece of a child's tumor to FoundationOne, an FDA-approved tissue-based broad companion diagnostic (CDx) for solid tumors, which provides the genomic alterations of that particular tumor. This explanation of the genetic aberrations includes its significance, best available treatment with mechanism of action and studies open for enrollment.

Manipulation of tumors based on molecular genetics began more than 35 years ago with shrinking prolactinomas before turning to neurosurgery. Boop and his team now use a molecular biological approach with medulloblastomas, low-grade gliomas, congenital glioblastomas and many more types of brain tumors. Closer study of molecular genetics has revealed different variants within each type of tumor, each with a different treatment approach and prognosis based on the genetic variant. Further study is needed into treatment side effects and long-term consequences for some of these therapies.

"As neurosurgeons, it is important for us to get tissue to the lab in every instance for us to understand what's going on so that these children can have a chance," said Boop.

For tumors that can't be removed surgically but tissue is needed for diagnostics, biopsies provide better understanding and treatment of the tumor. Previously, neurosurgeons avoided these biopsies because it was believed that the cells required were closest to necrotic areas that could cause catastrophic complications. Better understanding of tumors means that the tumor can be biopsied in a safer area in order to obtain the molecular profile of the tumor.

"Molecular genetics has completed changed our field and will continue to do so," said Boop. "There may come a time when the role for surgeons is much less than it is today."

Credit: 
Le Bonheur Children's Hospital

Friends fur life help build skills for life

image: A new UBC Okanagan study finds children reap the benefits of working with therapy dogs

Image: 
UBC Okanagan

A new UBC Okanagan study finds children not only reap the benefits of working with therapy dogs-they enjoy it too.

"Dog lovers often have an assumption that canine-assisted interventions are going to be effective because other people are going to love dogs," says Nicole Harris, who conducted this research while a master's student in the School of Education. "While we do frequently see children improve in therapy dog programs, we didn't have data to support that they enjoyed the time as well."

Harris was the lead researcher in the study that explored how children reacted while participating in a social skill-training program with therapy dogs.

The research saw 22 children from the Okanagan Boys and Girls Club take part in a series of sessions to help them build their social skills. Over six weeks, the children were accompanied by therapy dogs from UBC Okanagan's Building Academic Retention through K9s (BARK) program as they completed lessons.

Each week the children were taught a new skill, such as introducing themselves or giving directions to others. The children would first practice with their assigned therapy dog before running through the exercise with the rest of the group. In the final phase, the children --accompanied by their new furry friend and volunteer handler --would practice their new skills with university students located in the building.

"Therapy dogs are often able to reach children and facilitate their growth in surprising ways. We saw evidence of this in the social skills of children when they were paired with a therapy dog," says Dr. John-Tyler Binfet, associate professor in the School of Education and director of BARK. "The dogs helped create a non-threatening climate while the children were learning these new skills. We saw the children practice and hone their social skills with and alongside the dogs."

While the children were learning and practising their new skills, the research team collected data.

"Findings from our observations suggested that canine-assisted social and emotional learning initiatives can provide unique advantages," says Harris. "Our team saw that by interacting with the therapy dogs, the children's moods improved and their engagement in their lessons increased."

In fact, 87 per cent of the team rated the children's engagement level as very or extremely engaged during the sessions.

At the end of the six weeks, Harris interviewed eight children, aged 5 to 11 years old, who regularly attended the sessions. Each child indicated the social skill-training program was an enjoyable and positive experience and the dogs were a meaningful and essential part of the program.

One participant noticed that the children behaved better at the sessions than at their regular after-school care program, and they thought it was because the children liked being around the dogs.

Half of the children mentioned ways that they felt the dogs helped with their emotional well-being, with one participant crediting a dog with helping him "become more responsible and control his silliness."

As a full-time elementary school teacher, Harris notes that schools have become increasingly important in helping students develop social and emotional skills, and this research could contribute to the development of future school-based or after-school programs.

"Dogs have the ability to provide many stress-reducing and confidence-boosting benefits to children," says Harris. "It was really heartwarming to see the impact the program had on the kids."

Credit: 
University of British Columbia Okanagan campus

FSU College of Medicine researcher develops new possibilities to prevent sudden cardiac death

image: Assistant Professor of Biomedical Sciences Stephen Chelko, right, works in his laboratory with graduate student Maicon Landim-Vieira. Chelko's lab has published research providing important new insights about arrhythmogenic cardiomyopathy, a leading cause of sudden cardiac death among young athletes.

Image: 
Mark Bauer/FSU College of Medicine

Nearly a half-million people a year die from sudden cardiac death (SCD) in the U.S. -- the result of malfunctions in the heart's electrical system.

A leading cause of SCD in young athletes is arrhythmogenic cardiomyopathy (ACM), a genetic disease in which healthy heart muscle is replaced over time by scar tissue (fibrosis) and fat.

Stephen Chelko, an assistant professor of biomedical sciences at the Florida State University College of Medicine, has developed a better understanding of the pathological characteristics behind the disease, as well as promising avenues for prevention. His findings are published in the current issue of Science Translational Medicine.

Individuals with ACM possess a mutation causing arrhythmias, which ordinarily are non-fatal if managed and treated properly. However, Chelko shows that exercise not only amplifies those arrhythmias, but causes extensive cell death. Their only option is to avoid taking part in what should be a healthy and worthwhile endeavor: exercise.

"There is some awful irony in that exercise, a known health benefit for the heart, leads to cell death in ACM subjects," Chelko said. "Now, we know that endurance exercise, in particular, leads to large-scale myocyte cell death due to mitochondrial dysfunction in those who suffer from this inherited heart disease."

Several thousand mitochondria are in nearly every cell in the body, processing oxygen and converting food into energy. Considered the powerhouse of all cells (they produce 90 percent of the energy our bodies need to function properly), they also play another important role as a protective antioxidant.

As mitochondria fail to function properly, and myocyte cells in the heart die, healthy muscles are replaced by scar tissue and fatty cells. Eventually, the heart's normal electrical signals are reduced to an erratic and disorganized firing of impulses from the lower chambers, leading to an inability to properly pump blood during heavy exercise. Without immediate medical treatment, death occurs within minutes.

Chelko's research gets to the heart of the process involved in mitochondrial dysfunction.

"Ultimately, mitochondria become overwhelmed and expel 'death signals' that are sent to the nucleus, initiating large-scale DNA fragmentation and cell death," Chelko said. "This novel study unravels a pathogenic role for exercise-induced, mitochondrial-mediated cell death in ACM hearts."

In addition to providing a better understanding of the process involved, Chelko discovered that cell death can be prevented by inhibiting two different mitochondrial proteins. One such approach utilizes a novel targeting peptide developed for Chelko's research by the National Research Council in Padova, Italy.

That discovery opens avenues for the development of new therapeutic options to prevent myocyte cell death, cardiac dysfunction and the pathological progression leading to deadly consequences for people living with ACM.

Credit: 
Florida State University

Researchers ID blood protein that sheds light on common, post-operative complication

BOSTON - Delirium, a common syndrome among older adults, particularly in those who have recently undergone surgery, critically ill patients in the ICU, and in older patients with multiple health issues, is a form of acute confusion that is characterized by poor attention, disorientation, impaired memory, delusions, and abrupt changes in mood and behavior. Moreover, patients who experience delirium are at increased risk of long term cognitive decline. Recently, clinicians and scientists have recognized that delirium is one of the first signs of COVID-19 infection in older patients and that it occurs frequently in patients with severe COVID-19 disease.

In a new study led by an interdisciplinary team of gerontologists, geriatricians, precision medicine experts, and bioinformaticians at Beth Israel Deaconess Medical Center (BIDMC), researchers identified a single protein present in the blood that is associated with increased risk of post-operative delirium. The finding, published in the Journal of Gerontology: Medical Sciences, sheds light on a potential pathophysiological mechanism underlying delirium and paves the way for a non-invasive, cost-effective test to guide prediction, diagnosis and monitoring of delirium. While further study is needed, pre-operative blood tests for these proteins could help physicians determine which patients are at higher risk for developing delirium.

"Delirium is associated with more complications, longer hospitalizations, increased risk of long-term cognitive decline, dementia and mortality, and costs the U.S. healthcare system an estimated $182 billion each year," said first author Sarinnapha Vasunilashorn, PhD, Assistant Professor of Medicine at BIDMC and Harvard Medical School (HMS).

"Despite its pervasiveness, delirium remains a clinical diagnosis with no established tests to diagnose the condition," said co-senior author Towia Libermann, PhD, Director of the BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center. "The discovery of a reliable biomarker could change that."

Vasunilashorn, also a member of the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, and colleagues used a cutting edge proteomics platform, SOMAscan -- a large-scale quantitative analysis of the expression levels of proteins -- to evaluate proteins present in the blood from a patient cohort called SAGES (Successful Aging after Elective Surgery). Sponsored by the National Institute on Aging, SAGES follows 560 noncardiac surgical patients ages 70 and older with the goal of identifying novel biomarkers of delirium and its associated long-term cognitive outcomes.

"SAGES participants have been very generous with their time, participating in interviews to test their memory and thinking, and also donate small amounts of blood, before and immediately after their major elective surgery," said co-senior author Edward Marcantonio, MD, Section Chief for Research in the Division of General Medicine at BIDMC and Professor of Medicine at HMS. "We are now analyzing this stored blood with novel techniques, such as SOMAscan, to understand the biological basis of delirium, an incredibly challenging clinical problem."

The researchers' analysis of more than 1,300 proteins revealed a single protein (known as chitinase-3-like-protein-1, or CHI3L1/YKL-40) that was present at higher concentrations in the blood both before and after surgery in patients who experienced delirium as compared with patients who did not develop postoperative delirium. This protein -- itself linked to aging and age-related conditions including Alzheimer's disease -- plays a critical role in the body's type 2 immune response.

The team also found that patients who had high pre-operative levels of the protein CHI3L1/YKL-40 combined with high post-operative levels of an immune-related protein called interleukin-6 (or IL-6) were at increased risk of delirium.

"Our study specifically highlights the involvement of this highly specific immune activating protein in postoperative delirium, which may also play a role in COVID-19 associated delirium," said Libermann, who is also an Associate Professor of Medicine at Harvard Medical School. "In addition to providing a promising candidate for a delirium biomarker, our findings suggest a possible link between delirium, aging and Alzheimer's disease."

Credit: 
Beth Israel Deaconess Medical Center